DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zerit (Stavudine) - Adverse Event Reports - All Cases - Pregnancy

 



Index of reports > All cases (102) > Cases with Pregnancy (10)

Below is the selection of adverse event reports related to Zerit (Stavudine) that includes all cases where reactions include pregnancy.

Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08

Patient: female

Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Crixivan
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Fortovase
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Lamivudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Retrovir
    Dosage: exposure began in week ten of gestation.
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Videx
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Zerit
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Zidovudine
    Indication: HIV Infection
    Start date: 1997-01-01
    End date: 1997-01-01

Zidovudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01



Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Invirase
    Dosage: exposure during gestation.

Norvir
    Dosage: exposure during gestation.

Retrovir
    Dosage: exposure during delivery.
    Start date: 1999-07-02
    End date: 1999-07-02

Retrovir
    Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
    Indication: Prophylaxis
    Start date: 1999-07-02
    End date: 1999-08-10

Retrovir
    Administration route: Oral
    Start date: 1999-07-07
    End date: 1999-07-18

Videx
    Dosage: exposure during gestation.

Zerit
    Dosage: exposure during gestation.

Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol



Adverse event in female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30

Patient: female

Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic

Adverse event resulted in: hospitalization

Suspect drug(s):
Crixivan
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Epivir
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Fortovase
    Dosage: exposure began in week 29 of gestation.
    Indication: HIV Test Positive
    Start date: 1997-11-12
    End date: 1998-01-19

Lamivudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01

Retrovir
    Dosage: exposure began in week ten of gestation.
    Indication: HIV Test Positive
    Start date: 1997-07-01
    End date: 1998-01-19

Videx
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Zerit
    Dosage: exposure began in week two of gestation.
    Indication: HIV Test Positive
    Start date: 1997-05-29
    End date: 1997-07-01

Zidovudine
    Indication: HIV Infection
    Start date: 1997-01-01
    End date: 1997-01-01

Zidovudine
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 1998-01-01
    End date: 1998-03-01



Adverse event in 33 year old female receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from Japan on 2007-05-29

Patient: 33 year old female

Adverse reactions / side effects: Normal Newborn, Musculoskeletal Pain, Anaemia, Blood Triglycerides Increased, Pregnancy, Deep Vein Thrombosis

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-03

Viracept
    Dosage: viracept (nfv) 2200-2500 mg/day dosed
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-10

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-03

Other drugs received by patient: Retrovir



Adverse event in 28 month old female receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29

Patient: 28 month old female

Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: from the 17th week of gestation to the 26th week.
    Start date: 1997-11-01
    End date: 1998-04-01

Epivir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-11-01
    End date: 1998-01-01

Invirase
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Norvir
    Dosage: from the 17th week to the end of pregnancy.
    Start date: 1997-11-01
    End date: 1998-04-01

Retrovir
    Dosage: from the 13th week to the 26th week of gestation.
    Start date: 1997-10-01
    End date: 1998-01-01

Retrovir
    Dosage: syrup
    Administration route: Oral
    Start date: 1997-10-01
    End date: 1998-01-01

Videx
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14

Zerit
    Dosage: from the 26th week of gestation.
    Start date: 1998-01-14



Adverse event in 33 year old female receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from Japan on 2007-05-01

Patient: 33 year old female

Adverse reactions / side effects: Anaemia, Musculoskeletal Pain, Blood Triglycerides Increased, Pregnancy, Deep Vein Thrombosis, Infant

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-03

Viracept
    Dosage: viracept (nfv) 2200-2500 mg/day dosed
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-10

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-03



Adverse event in female receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from Botswana on 2007-03-01

Patient: female, weighing 3.0 kg (6.6 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Vitiligo, Pregnancy, Umbilical Hernia

Suspect drug(s):
Epivir
    Start date: 2004-06-01
    End date: 2005-04-09

Viramune
    Start date: 2004-06-01
    End date: 2005-04-09

Zerit
    Start date: 2004-06-01
    End date: 2005-04-09



Adverse event in male receiving Zerit (Stavudine)

Reported by a physician from United States on 2007-02-15

Patient: male

Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy

Adverse event resulted in: disablity

Suspect drug(s):
Efavirenz
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Epivir
    Start date: 2005-02-23

Retrovir
    Start date: 2005-12-29

Viramune
    Start date: 2005-12-29

Zerit
    Start date: 2005-02-23
    End date: 2005-12-29

Other drugs received by patient: Bactrim; Vitamin B Complex CAP



Adverse event in male receiving Zerit (Stavudine)

Reported by a physician from United States on 2007-02-09

Patient: male

Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy

Adverse event resulted in: disablity

Suspect drug(s):
Efavirenz
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Epivir
    Start date: 2005-02-23

Retrovir
    Start date: 2005-12-29

Viramune
    Start date: 2005-12-29

Zerit
    Start date: 2005-02-23
    End date: 2005-12-29

Other drugs received by patient: Bactrim; Vitamin B Complex CAP



Adverse event in female receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from United States on 2007-01-12

Patient: female

Adverse reactions / side effects: Anaemia, Thrombocythaemia, Pregnancy, Blood Lactic Acid Increased, Hypertriglyceridaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Administration route: Oral
    Start date: 1999-02-19

Retrovir
    Indication: HIV Test Positive
    Start date: 1999-02-19

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-19

Zerit
    Administration route: Oral
    Start date: 1999-02-19

Other drugs received by patient: Methadone HCL

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009